07Investor Access

A dual-track platform for healthcare value creation.

Combining venture upside with recurring operating dividends. For qualified institutional investors and family offices.

7.1Dual-Track Return Model

A capital architecture designed to capture alpha while securing base-case yield.

Venture Track — 70% Allocation

Capital Multiplier

3–5x MoIC

Target IRR: 30–40%
Instrument: Direct Class A equity
Realization: 5–7 year window

Direct equity deployment into emerging-growth MedTech leaders within the MENA corridor. Value creation driven by commercial scaling.

Operating Track — 30% Allocation

Annual Performance

15% IRR

Distribution Profile: Recurring Dividends
Source: CMO & Care Solutions
Cash-Yield Year: From Year 3

Cash-flow positive deployment into CMO & Care Solutions. Systematic yield generated through operational excellence.

Platform

Synthesis

Synthesis Outcome [Illustrative]

>40%Cumulative Platform IRR

Modelled on a standard USD 10,000,000 allocation portfolio.

Allocation Split

70% Growth / 30% Yield

Liquidity Window

3–5 Year Target Realization

7.2Capital Structure

Vehicle: Merova Healthcare Holding Limited — Abu Dhabi
Instrument: Class A Preferred Shares
Investor Profile: Qualified institutional investors and family offices
Target Platform IRR: >40% cumulative [Target]
Reporting: Quarterly NAV · annual audited financials
Governance: Investment Committee · independent advisory board

7.3Illustrative Example

A USD 10M allocation, modelled across both tracks.

Allocation

USD 10,000,000

Venture Track · 70%

USD 7M deployed across emerging-growth MedTech · 3–5x MoIC over 5–7 years [Projected]

Operating Track · 30%

USD 3M into CMO & Care Solutions equity · 15% recurring IRR from year 3 [Target]

Blended Outcome [Illustrative]

>40% Cumulative Platform IRR

Target only. Projected, actual results may vary.

Request investor materialsHow the platform operates →

Forward-Looking Statement

This presentation and any accompanying materials may contain forward-looking statements within the meaning of applicable securities laws. These statements are based on the current expectations, assumptions, and beliefs of Merova Healthcare Holding Limited ("Merova") and involve risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. Forward-looking statements include, but are not limited to, expectations regarding investment performance, anticipated returns, the growth and success of portfolio companies, future financial results, operational plans, and strategic initiatives. Statements that include words such as "anticipate," "believe," "expect," "intend," "plan," "may," "will," "should," "could," "estimate," and similar expressions are intended to identify such forward-looking statements. Actual results may differ significantly due to various risks and uncertainties, including but not limited to market conditions, regulatory changes, the ability of investee companies to achieve their business objectives, supply chain disruptions, competition, general economic conditions, and other factors beyond Merova's control. There can be no assurance that any forward-looking statements will prove to be accurate, and past performance is not indicative of future results. Merova undertakes no obligation to update or revise any forward-looking statements except as required by law. Prospective investors should conduct their own independent assessment of Merova's investment strategy, risks, and opportunities and should consult their own legal, financial, and tax advisors before making any investment decisions.